Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | Leerink Partners | Maintained | Market Perform | $40 $90 | Sep 29 |
| ILMNIllumina, Inc. | Leerink Partners | Maintained | Outperform | $220 $300 | Sep 29 |
| BRKRBruker Corporation | Leerink Partners |
Showing the 14 most recent target moves.
| Maintained |
| Outperform |
| $60 $80 |
| Sep 29 |
| TWSTTwist Bioscience Corporation | Leerink Partners | Maintained | Outperform | $160 $190 | Sep 29 |
| ISRGIntuitive Surgical, Inc. | Leerink Partners | Maintained | Outperform | $473 $503 | 4d ago |
| UTHRUnited Therapeutics Corporation | Leerink Partners | Maintained | Outperform | $685 $725 | 6d ago |
| MCKMcKesson Corporation | Leerink Partners | Maintained | Outperform | $1,030 $1,070 | Oct 7 |
| CORCencora, Inc. | Leerink Partners | Maintained | Outperform | $380 $388 | Oct 7 |
| LLYEli Lilly and Company | Leerink Partners | Maintained | Outperform | $1,309 $1,316 | 4d ago |
| JNJJohnson & Johnson | Leerink Partners | Maintained | Outperform | $276 $272 | Oct 14 |
| HSICHenry Schein, Inc. | Leerink Partners | Maintained | Market Perform | $96 $92 | Oct 14 |
| CVSCVS Health Corporation | Leerink Partners | Maintained | Outperform | $119 $112 | Oct 12 |
| ALGNAlign Technology, Inc. | Leerink Partners | Maintained | Outperform | $235 $215 | Oct 14 |
| BMYBristol-Myers Squibb Company | Leerink Partners | Downgraded from Outperform | Market Perform | $73 $59 | Oct 5 |